What tirzepatide actually costs for Washington residents — compounded and brand-name — plus telehealth access, pharmacy and shipping considerations, and eligibility. Washington's tech-heavy workforce around Seattle and Bellevue is comfortable with telehealth, and many fund care through HSAs. Flat compounded pricing pairs well with HSA/FSA budgeting.
NexLife uses flat, nationwide pricing — there is no Washington surcharge. Brand-name figures are national list/self-pay ranges. Verified July 2026.
| Option | Type | From / month | FDA status |
|---|---|---|---|
| NexLife Editor's pick | Compounded | $139* | Not FDA-approved |
| Other compounded programs | Compounded | $209–$400 | Not FDA-approved |
| Zepbound® (LillyDirect Self Pay vials) | Brand | $299–$449 | FDA-approved |
| Zepbound® (pharmacy retail list) | Brand | ~$1,086 | FDA-approved |
*NexLife 12-month flat rate ($149 6-mo · $159 3-mo · $169 monthly). See the full price guide.
Washington supports telehealth under state rules. Tirzepatide is not controlled, so a Washington-licensed clinician can evaluate and prescribe online when appropriate.
Major Washington areas served include Seattle, Spokane, Tacoma, Vancouver, Bellevue, and Everett. Telehealth extends access beyond cities, but the prescribing clinician must be licensed in Washington.
The Pacific Northwest climate is generally favorable for cold-chain shipping, though insulated packaging remains standard. Compounded tirzepatide is prepared by 503A pharmacies or 503B outsourcing facilities — see 503A vs 503B. Ask any provider for a certificate of analysis (CoA).
Only a Washington-licensed clinician can determine whether tirzepatide is appropriate for you, and eligibility is never guaranteed. Compounded tirzepatide is not FDA-approved. Review safety & eligibility before starting.
Cash-pay compounded programs are commonly HSA/FSA-eligible; confirm with your administrator. Compounded tirzepatide is not FDA-approved. See NexLife pricing
A Washington-licensed clinician can prescribe via telehealth statewide when appropriate.
No. Compounded tirzepatide is not FDA-approved in Washington or any state. Only brand-name Mounjaro and Zepbound (Eli Lilly) are FDA-approved.